Health Care
Coronavirus
PRI Covid Tradeoffs Brief Receives National Coverage
PRI Brief on Tradeoffs from COVID-19 Restrictions Featured in National Review
Economist Wayne Winegarden and policy associate McKenzie Richards of the nonpartisan, pro-free-market Pacific Research Institute recently authored a research brief detailing how more-severe Covid-19 mitigation policies — namely lockdowns, masking mandates, school and business closures, and social distancing — led to reduced infection and mortality rates, but at the expense of ...
Commentary
Read latest about single-payer healthcare
Most Americans don’t want Medicare for All
But according to recent polling, neither claim is true. Americans are broadly happy with the existing health insurance system. And single-payer would manifestly worsen — not solve — the problems Americans do face under the status quo. Read the full article at the Boston Herald
Commentary
Read about government health care mandates
Healthcare provider shortages are a symptom of government red tape
The unions cited inadequate staffing ratios as a primary motivator for the strike. Labor shortages, or suboptimal distributions of healthcare personnel, are common across the country. Government red tape is largely to blame. Cutting that red tape could make it easier for millions of patients to access care. Read the ...
Commentary
Learn about rising government health care spending
Healthcare Subsidies? A Ticking Time-Bomb
A new study from the Congressional Budget Office (CBO) makes this startlingly clear. The federal government spent a jaw-dropping $1.8 trillion on healthcare subsidies this year, the CBO says. In 2033, federal subsidies for healthcare are projected to reach $3.3 trillion. Read the full article at Newsmax
Commentary
Read latest about problems with PBMs
Decoupling PBM Fees Enhances Patient Outcomes
The three largest PBMs—Caremark (CVS Health/Aetna AET 0.0%), Express Scripts ESRX 0.0% (Cigna CI +0.7%), and OptumRx (UnitedHealth Group UNH +0.2%)—control 80% of the market and are integrated into large health insurance conglomerates. PBMs negotiate drug prices with pharmaceutical companies on behalf of insurers and manage their drug formularies. Read ...
Commentary
Price Controls On Doctors Are A Pathway To Socialized Medicine
Advocates for Medicare for All and other socialized medicine schemes are now in pole position. Although government distortions drive the system’s adverse outcomes, the U.S. is now on autopilot driving toward a full socialized healthcare system. Read the full article at Forbes.com
Commentary
Improving The FDA’s Regulatory Process Can Enhance Treatment Options
Peter Marks, director of Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research noted that “vaccination remains critical to public health and continued protection against serious consequences of Covid-19, including hospitalization and death.” But what is the protection for those Americans who can’t take the vaccine? Read the ...
Commentary
This Healthcare Reform Could Finally Bring Democrats And Republicans Together
Is there anything that can bring Democrats and Republicans together on health care? Democrats support a greater role for government in the provision of—and payment for—health care. Republicans generally push for deregulation, consumerism, and competition. So what about a healthcare policy that would encourage individuals to shop around for coverage ...
Commentary
Learn about states and Medicaid disenrollment
States Are Wasting Money by Slow-Rolling Medicaid Reviews
During the COVID-19 public health emergency, Congress forbade states from disenrolling people from Medicaid. The idea was to prevent people from losing coverage during the pandemic. But the emergency is over. On April 1, state Medicaid programs regained the ability to drop people no longer eligible. Some states have moved ...
Covid-19
Wayne Winegarden on Lars Larson Show: Did Covid Restrictions Wreck Our Economy For Nothing?
Listen to Dr. Wayne Winegarden, PRI senior fellow in business and economics and director of PRI’s Center for Medical Economics and Innovation, discuss his new brief “No Solutions, Only Tradeoffs,” which explores how the small health benefits generated by state COVID-19 lockdowns were more than offset by huge losses in ...
PRI Covid Tradeoffs Brief Receives National Coverage
PRI Brief on Tradeoffs from COVID-19 Restrictions Featured in National Review
Economist Wayne Winegarden and policy associate McKenzie Richards of the nonpartisan, pro-free-market Pacific Research Institute recently authored a research brief detailing how more-severe Covid-19 mitigation policies — namely lockdowns, masking mandates, school and business closures, and social distancing — led to reduced infection and mortality rates, but at the expense of ...
Read latest about single-payer healthcare
Most Americans don’t want Medicare for All
But according to recent polling, neither claim is true. Americans are broadly happy with the existing health insurance system. And single-payer would manifestly worsen — not solve — the problems Americans do face under the status quo. Read the full article at the Boston Herald
Read about government health care mandates
Healthcare provider shortages are a symptom of government red tape
The unions cited inadequate staffing ratios as a primary motivator for the strike. Labor shortages, or suboptimal distributions of healthcare personnel, are common across the country. Government red tape is largely to blame. Cutting that red tape could make it easier for millions of patients to access care. Read the ...
Learn about rising government health care spending
Healthcare Subsidies? A Ticking Time-Bomb
A new study from the Congressional Budget Office (CBO) makes this startlingly clear. The federal government spent a jaw-dropping $1.8 trillion on healthcare subsidies this year, the CBO says. In 2033, federal subsidies for healthcare are projected to reach $3.3 trillion. Read the full article at Newsmax
Read latest about problems with PBMs
Decoupling PBM Fees Enhances Patient Outcomes
The three largest PBMs—Caremark (CVS Health/Aetna AET 0.0%), Express Scripts ESRX 0.0% (Cigna CI +0.7%), and OptumRx (UnitedHealth Group UNH +0.2%)—control 80% of the market and are integrated into large health insurance conglomerates. PBMs negotiate drug prices with pharmaceutical companies on behalf of insurers and manage their drug formularies. Read ...
Price Controls On Doctors Are A Pathway To Socialized Medicine
Advocates for Medicare for All and other socialized medicine schemes are now in pole position. Although government distortions drive the system’s adverse outcomes, the U.S. is now on autopilot driving toward a full socialized healthcare system. Read the full article at Forbes.com
Improving The FDA’s Regulatory Process Can Enhance Treatment Options
Peter Marks, director of Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research noted that “vaccination remains critical to public health and continued protection against serious consequences of Covid-19, including hospitalization and death.” But what is the protection for those Americans who can’t take the vaccine? Read the ...
This Healthcare Reform Could Finally Bring Democrats And Republicans Together
Is there anything that can bring Democrats and Republicans together on health care? Democrats support a greater role for government in the provision of—and payment for—health care. Republicans generally push for deregulation, consumerism, and competition. So what about a healthcare policy that would encourage individuals to shop around for coverage ...
Learn about states and Medicaid disenrollment
States Are Wasting Money by Slow-Rolling Medicaid Reviews
During the COVID-19 public health emergency, Congress forbade states from disenrolling people from Medicaid. The idea was to prevent people from losing coverage during the pandemic. But the emergency is over. On April 1, state Medicaid programs regained the ability to drop people no longer eligible. Some states have moved ...
Wayne Winegarden on Lars Larson Show: Did Covid Restrictions Wreck Our Economy For Nothing?
Listen to Dr. Wayne Winegarden, PRI senior fellow in business and economics and director of PRI’s Center for Medical Economics and Innovation, discuss his new brief “No Solutions, Only Tradeoffs,” which explores how the small health benefits generated by state COVID-19 lockdowns were more than offset by huge losses in ...
